Inicio › Cáncer del colon y del recto › Minnesota
Ensayos clínicos de Cáncer del colon y del recto en Minnesota
45 estudios sobre Cáncer del colon y del recto buscan participantes en Minnesota.
Ciudades en Minnesota
- Rochester29 estudios
- Minneapolis19 estudios
- Plymouth9 estudios
- Saint Paul9 estudios
- Bloomington7 estudios
- Brooklyn Park7 estudios
- Duluth5 estudios
Texto oficial del estudio (inglés)
PRE-ISPY Phase I/II Oncology Platform Program
- University of Minnesota Masonic Cancer Center, Minneapolis
- Mayo Clinic Comprehensive Cancer Center, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT05868226Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Avera Cancer Institute- Marshall, Marshall
- Mayo Clinic Hospital, Methodist Campus, Research Pharmacy, Rochester
- Mayo Clinic Pharmacy, Rochester
- y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07222800Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Rochester, Rochester
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT05863195A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- Minnesota Oncology, Maple Grove
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07221357Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Mayo Clinic, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06445062A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Mayo Clinic - Rochester, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Masonic Cancer Center University of Minnesota, Minneapolis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT05786924An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
- Mayo Clinic in Rochester, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT06557733A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Mayo Clinic Rochester, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT04929223A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Minnesota Oncology Hematology, P.A., Saint Louis Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07549412Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Clinical Study Site, Saint Louis Park
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT07228832Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
- Sanford Joe Lueken Cancer Center, Bemidji
- Regions Hospital, Saint Paul
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT05673148FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- University of Minnesota Masonic Cancer Center, Minneapolis
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07216105The Vanguard Study: Testing a New Way to Screen for Cancer
- Minneapolis VA Medical Center, Minneapolis
ReclutandoSe aceptan voluntarios sanos
Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Riverwood Healthcare Center, Aitkin
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health - Baxter Clinic, Baxter
- y 48 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069Family Communications After Genetic Testing
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- y 41 más
ReclutandoSe aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07143487Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
ReclutandoFase 1/2
12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
- Mayo Clinic, Rochester
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT05410977A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
- Research Site, Rochester
ReclutandoFase 2
Edades de 18 a 130 · Todos los sexos · Actualizado el 18 ago 2026 · NCT06792695FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05919264A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- M Health Fairview University of Minnesota Medical Center, Minneapolis
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06330064Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #68, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT05176483Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Health Partners Cancer Center at Regions Hospital, Saint Paul
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT07397338A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Minnesota Oncology Hematology, Maple Grove
- Mayo Clinic (Minnesota), Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2026 · NCT04657068Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Mayo Clinic Rochester, Rochester
ReclutandoFase 1
Edades de 18 a 100 · Todos los sexos · Actualizado el 29 jul 2026 · NCT06562192A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Mayo Clinic Cancer Center, Rochester
- Mayo Clinic, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT06131840A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
- Minnesota Oncology Hematology, PA, Burnsville
- Allina Health Cancer institute, Coon Rapids
- Minnesota Oncology Hematology, PA, Coon Rapids
- y 17 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT05253651A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- May Clinic Rochester, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 jul 2026 · NCT06948448A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
- Mayo Clinic-Rochester /ID# 273508, Rochester
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 jul 2026 · NCT07023289Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Mayo Clinic in Rochester, Minnesota, Rochester
ReclutandoFase 1/2
Edades de 18 a 90 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06710756A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Minnesota Oncology Hematology - Primary, Maple Grove
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT07011576A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Mayo Clinic Comprehensive Cancer Center, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jun 2026 · NCT06026410A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Mayo Clinic, Rochester, Rochester
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 abr 2026 · NCT06720987Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Essentia Health Saint Joseph's Medical Center, Brainerd
- y 38 más
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 en adelante · Todos los sexos · Actualizado el 31 mar 2026 · NCT07018869A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Mayo Clinic Health System in Albert Lea, Albert Lea
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Minnesota Oncology - Burnsville, Burnsville
- y 31 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 17 mar 2026 · NCT06418204Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Mayo Clinic in Rochester, Rochester
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 mar 2026 · NCT06349642cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Allina Health Cancer Institute, Minneapolis
- Mayo Clinic, Rochester
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881De ClinicalTrials.gov, datos obtenidos el 1 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.